Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 6,999 | 0 | 677 | 7,679 | 0 |
| Gross Profit | 6,999 | N/A | 677 | 7,679 | N/A |
| Operating Expenses | 67,630 | 80,391 | 77,524 | 92,548 | 84,979 |
| Operating Income | -60,631 | -80,391 | -76,847 | -84,869 | -84,979 |
| Other Income | 5,741 | 6,242 | 6,472 | 7,804 | 8,975 |
| Pre-tax Income | -54,890 | -74,149 | -70,375 | -77,065 | -76,004 |
| Net Income Continuous | -54,890 | -74,149 | -70,375 | -77,065 | -76,004 |
| Net Income | $-54,890 | $-74,149 | $-70,375 | $-77,065 | $-76,004 |
| EPS Basic Total Ops | -0.31 | -0.43 | -0.41 | -0.46 | -0.42 |
| EPS Basic Continuous Ops | -0.31 | -0.43 | -0.41 | -0.46 | -0.42 |
| EPS Diluted Total Ops | -0.31 | -0.43 | -0.41 | -0.46 | -0.42 |
| EPS Diluted Continuous Ops | -0.31 | -0.43 | -0.41 | -0.46 | -0.42 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.43 | -0.41 | -0.46 | -0.45 |
| EBITDA(a) | $-60,889 | $-80,744 | $-74,939 | $-85,258 | $-85,826 |